Livent Corporation(LTHM) Stock Research - Grey Stern Research

Livent Corporation (LTHM) Stock Analysis

$16.51 (-8.53%)

LTHM Financial Performance


Use the table below to view Livent Corporation's financial profile. This data is gathers from the latest available financial statements. Annual data is taken from the trailing 12 months of statements. All numbers are reported in US Dollars and so any foreign currencies are converted to USD so comparison's can be done.

Based on Financial Statements from Q3 - 2023

Metric Value Ranking among Peers
Price $16.51 -
52 Week Low $5.20 -
52 Week High $17.51 -
Market Cap $3.0 Billion 10/13
Gross Margin 55% 3/13
Profit Margin 41% 1/13
EBITDA margin 52% 3/13
Q3 - 2023 Revenue $211.4 Million 11/13
Q3 - 2023 Earnings $87.4 Million 9/13
Q3 - 2023 Free Cash Flow $80.2 Million 6/13
Trailing 4 Quarters Revenue $932.3 Million 11/13
Trailing 4 Quarters Earnings $370.0 Million 8/13
Quarterly Earnings Growth 46% 4/13
Annual Earnings Growth 54% 2/13
Quarterly Revenue Growth -3% 6/13
Annual Revenue Growth 7% 3/13
Cash On Hand $112.6 Million 10/13
Short Term Debt $0 13/13
Long Term Debt $243.1 Million 12/13

Livent Corporation Financial Metrics


Financial metrics are a set of useful numbers that can give key performance indicators of a company. The various metrics can include information about profitability, growth, and debt load. When combined and use properly they can tell an analyst a compelling fact-based story of how the company is currently performing. To compare Livent Corporation's metrics versus it's peers make sure to run our peer analysis tool.

Valuation Metrics

Metric Value Ranking among Peers
PE 8.03 8/13
PS 3.19 5/13
PB 1.71 8/13
PC 26.38 4/13
Liabilities to Equity 0.36 11/13
ROA 0.16 2/13
ROE 0.21 3/13
Current Ratio 3.81 1/13
Quick Ratio 0.18 4/13
Long Term Debt to Equity 0.14 12/13
Debt to Equity 0.14 12/13
Burn Rate -1.45 8/13
Cash to Cap 0.04 8/13
CCR 0.92 5/13
EV to EBITDA 28.04 7/13
EV to Revenue 3.33 6/13

Company Details

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

CEO: Mr. Paul Graves

Website: https://livent.com

Address: 2929 Walnut St Philadelphia, PENNSYLVANIA

Exchange: New York Stock Exchange

Industry: Specialty Chemicals

Livent Corporation Peer Analysis


A useful and more reliable way of seeing the health of a company is to compare it to other companies operating in the same sector. Below is our list of companies which we rank are the closest peers to Livent Corporation. If you feel that peers should be added or removed from this list please contact us. To run an in-depth peer analysis which compares many financial metrics click on the link below.

Stock Ticker Market Cap
LyondellBasell Industries N.V. LYB $24.7 Billion
Sociedad Química y Minera de Chile S.A. SQM $10.6 Billion
Albemarle Corporation ALB $11.2 Billion
Ecolab Inc. ECL $67.0 Billion
PPG Industries, Inc. PPG $27.3 Billion
The Sherwin-Williams Company SHW $87.4 Billion
Air Products and Chemicals, Inc. APD $68.2 Billion
Amyris, Inc. AMRS $0
DuPont de Nemours, Inc. DD $31.9 Billion
Linde plc LIN $203.8 Billion
Alto Ingredients, Inc. ALTO $126.5 Million
Danimer Scientific, Inc. DNMR $4.7 Million
Run Peer Analysis
Income Statement
Balance Sheet
Cash Flow Statement
LTHM Income Statements
Quarter Year Revenue Earnings
Q3 2023 $ 211.4 Million $87.4 Million
Q2 2023 $ 235.8 Million $90.2 Million
Q1 2023 $ 253.5 Million $114.8 Million
Q3 2022 $ 231.6 Million $77.6 Million
Q2 2022 $ 218.7 Million $60.0 Million
Q4 2022 $ 218.7 Million $60.0 Million
Q1 2022 $ 143.5 Million $53.2 Million
Q4 2021 $ 122.9 Million $7.5 Million

View All

LTHM Balance Sheets
Quarter Year Cash & Equivalents Total Assets Total Debt Total Equity
Q3 2023 $112.6 Million $2.4 Billion $243.1 Million $1.7 Billion
Q2 2023 $167.8 Million $2.3 Billion $242.7 Million $1.7 Billion
Q1 2023 $194.1 Million $2.2 Billion $242.3 Million $1.6 Billion
Q3 2022 $211.6 Million $2.0 Billion $259.2 Million $1.6 Billion
Q2 2022 $49.0 Million $1.7 Billion $260.3 Million $1.3 Billion
Q4 2022 $49.0 Million $1.7 Billion $259.2 Million $1.3 Billion
Q1 2022 $68.5 Million $1.2 Billion $245.8 Million $876.5 Million
Q4 2021 $113.0 Million $1.2 Billion $241.5 Million $795.4 Million

View All

LTHM Cash Flow Statements
Quarter Year freeCashFlow capitalExpenditure netChangeInCash
Q3 2023 $80.2 Million $0 -$55.2 Million
Q2 2023 $78.7 Million $0 -$26.3 Million
Q1 2023 $29.4 Million -$73.5 Million $5.1 Million
Q4 2022 $17.9 Million -$108.6 Million -$22.6 Million
Q3 2022 $175.3 Million -$91.7 Million $162.6 Million
Q2 2022 -$17.5 Million -$67.9 Million -$19.5 Million
Q1 2022 -$57.9 Million -$68.7 Million -$44.5 Million
Q4 2021 $54.8 Million -$62.5 Million -$82.3 Million

View All

Cookies

We use cookies to offer a better browsing experience. Cookies enhance site navigation, analyze site usage, and assist in our marketing efforts. By clicking Accept. you agree to the storing of cookies on your device. To refuse all non-required cookies, click on Decline.

Accept View Terms & Conditions